| Not Yet Recruiting | Clinical Trial of NS-863 in Participants With Pulmonary Arterial Hypertension (PAH) Pulmonary Arterial Hypertension | Phase 2 | 2026-07-01 |
| Not Yet Recruiting | A Clinical Trial of NS-863 in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disea Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) | Phase 2 | 2026-07-01 |
| Recruiting | NS-050/NCNP-03 in Boys With DMD (Meteor50) Duchenne Muscular Dystrophy | Phase 1 / Phase 2 | 2024-09-18 |
| Recruiting | NS-089/NCNP-02-201 in Boys With Duchenne Muscular Dystrophy (DMD) Duchenne Muscular Dystrophy, Exon 44, DMD | Phase 2 | 2024-02-22 |
| Recruiting | Trial of Efficacy and Safety of NS-229 Versus Placebo in Patients With Eosinophilic Granulomatosis With Polyan Eosinophilic Granulomatosis With Polyangiitis, Churg-Strauss Syndrome | Phase 2 | 2023-12-20 |
| Terminated | Study to Assess Efficacy and Safety of NS-018 Compared to BAT in Patients With Myelofibrosis Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, Post-polycythemia Vera Myelofibrosis | Phase 2 | 2023-01-31 |
| Completed | Study to Assess the Safety, Tolerability, and Efficacy of Viltolarsen in Ambulant and Non-Ambulant Boys With D Duchenne Muscular Dystrophy | Phase 2 | 2021-07-01 |
| Active Not Recruiting | Long-term Use of Viltolarsen in Boys With Duchenne Muscular Dystrophy in Clinical Practice (VILT-502) Duchenne Muscular Dystrophy | Phase 4 | 2021-06-10 |
| Unknown | Study to Assess the Safety and Efficacy of Viltolarsen in Ambulant Boys With DMD (RACER53-X) Duchenne Muscular Dystrophy | Phase 3 | 2021-04-13 |
| Completed | Study to Assess the Efficacy and Safety of Viltolarsen in Ambulant Boys With DMD (RACER53) Duchenne Muscular Dystrophy | Phase 3 | 2020-04-14 |
| Completed | Extension Study of NS-065/NCNP-01 in Boys With Duchenne Muscular Dystrophy (DMD) Duchenne Muscular Dystrophy | Phase 2 | 2017-07-06 |
| Completed | Safety and Dose Finding Study of NS-065/NCNP-01 in Boys With Duchenne Muscular Dystrophy (DMD) Duchenne Muscular Dystrophy | Phase 2 | 2016-12-01 |
| Completed | Safety and Tolerability Study of Oral NS-018 in Patients With Primary Myelofibrosis (MF), Post-polycythemia Ve Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis | Phase 1 / Phase 2 | 2011-06-01 |
| Completed | Study of NS-9 in Patients With Liver Metastases Liver Neoplasms, Neoplasm Metastasis, Local Neoplasm Recurrences | Phase 1 | 2002-09-01 |
| Approved For Marketing | The Expanded Access Use of Viltolarsen in Duchenne Muscular Dystrophy With Confirmed Exon 53 Amenable Mutation Muscular Dystrophy, Duchenne, DMD | — | — |